These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 19683086

  • 1. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
    Gilca V, De Serres G, Boulianne N, De Wals P, Murphy D, Trudeau G, Massé R, Duval B.
    Vaccine; 2009 Oct 09; 27(43):6048-53. PubMed ID: 19683086
    [Abstract] [Full Text] [Related]

  • 2. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A, Montazerifar SJ.
    J Ayub Med Coll Abbottabad; 2006 Oct 09; 18(4):4-9. PubMed ID: 17591001
    [Abstract] [Full Text] [Related]

  • 3. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
    Zhuang GH, Yan H, Wang XL, Wu Q, Wang LR, Gao HY.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan 09; 40(1):8-12. PubMed ID: 16620590
    [Abstract] [Full Text] [Related]

  • 4. [Are teenagers immunized in infancy still protected against hepatitis B?].
    Pokorska-Lis M, Marczyńska M.
    Przegl Lek; 2010 Jan 09; 67(1):13-7. PubMed ID: 20509565
    [Abstract] [Full Text] [Related]

  • 5. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct 09; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 6. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
    Gabbuti A, Romanò L, Blanc P, Meacci F, Amendola A, Mele A, Mazzotta F, Zanetti AR.
    Vaccine; 2007 Apr 20; 25(16):3129-32. PubMed ID: 17291637
    [Abstract] [Full Text] [Related]

  • 7. [Vaccination against hepatitis B possibly indicated for elderly institutionalized mentally handicapped persons with isolated anti-HBc positivity of the prevaccination serum].
    Vrijmoeth P, Heijtink RA, Schreuder H, Kroes AC.
    Ned Tijdschr Geneeskd; 1997 Aug 30; 141(35):1694-7. PubMed ID: 9543786
    [Abstract] [Full Text] [Related]

  • 8. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.
    Vaccine; 2012 Jun 08; 30(27):4034-9. PubMed ID: 22531558
    [Abstract] [Full Text] [Related]

  • 9. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
    Chlibek R, Smetana J, Bostíková V, Splino M.
    Epidemiol Mikrobiol Imunol; 2011 Sep 08; 60(3):99-108. PubMed ID: 22132651
    [Abstract] [Full Text] [Related]

  • 10. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, Lu J, Sun Z, Qu C.
    Vaccine; 2011 Oct 13; 29(44):7835-41. PubMed ID: 21816197
    [Abstract] [Full Text] [Related]

  • 11. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
    Yao J, Ren J, Shen L, Chen Y, Liang X, Cui F, Li Q, Jiang Z, Wang F.
    Hum Vaccin; 2011 Oct 13; 7(10):1055-9. PubMed ID: 21989290
    [Abstract] [Full Text] [Related]

  • 12. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
    Yuen MF, Lim WL, Cheng CC, Lam SK, Lai CL.
    Hepatology; 1999 Mar 13; 29(3):924-7. PubMed ID: 10051499
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C.
    Am J Gastroenterol; 2012 Jan 13; 107(1):133-8. PubMed ID: 21876562
    [Abstract] [Full Text] [Related]

  • 14. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A, Karimi G, Shaiegan M, Maghsudlu M, Tabbaroki A.
    Pediatr Hematol Oncol; 2009 Jun 13; 26(4):195-201. PubMed ID: 19437322
    [Abstract] [Full Text] [Related]

  • 15. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
    Li H, Li R, Liao S, Yang J, Zeng X.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb 13; 20(1):54-9. PubMed ID: 11367735
    [Abstract] [Full Text] [Related]

  • 16. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A, Study Group.
    Lancet; 1998 Feb 13; 366(9494):1379-84. PubMed ID: 16226616
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination.
    Su FH, Cheng SH, Li CY, Chen JD, Hsiao CY, Chien CC, Yang YC, Hung HH, Chu FY.
    Vaccine; 2007 Nov 19; 25(47):8085-90. PubMed ID: 17920732
    [Abstract] [Full Text] [Related]

  • 18. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
    Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M.
    Vaccine; 2011 Mar 09; 29(12):2302-7. PubMed ID: 21277403
    [Abstract] [Full Text] [Related]

  • 19. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.
    McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW.
    J Infect Dis; 2009 Nov 01; 200(9):1390-6. PubMed ID: 19785526
    [Abstract] [Full Text] [Related]

  • 20. Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine.
    Gilca V, De Serres G, Boulianne N, Murphy D, De Wals P, Ouakki M, Trudeau G, Massé R, Dionne M.
    Vaccine; 2013 Jan 07; 31(3):448-51. PubMed ID: 23206974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.